"Hypersensitivity, Delayed" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An increased reactivity to specific antigens mediated not by antibodies but by cells.
- Hypersensitivity, Delayed
- Hypersensitivity, Type IV
- Hypersensitivities, Type IV
- Type IV Hypersensitivities
- Delayed Hypersensitivity
- Delayed Hypersensitivities
- Hypersensitivities, Delayed
- Type IV Hypersensitivity
- Hypersensitivity, Tuberculin-Type
- Hypersensitivities, Tuberculin-Type
- Hypersensitivity, Tuberculin Type
- Tuberculin-Type Hypersensitivities
- Tuberculin-Type Hypersensitivity
- Tuberculin Type Hypersensitivity
Below are MeSH descriptors whose meaning is more general than "Hypersensitivity, Delayed".
Below are MeSH descriptors whose meaning is more specific than "Hypersensitivity, Delayed".
This graph shows the total number of publications written about "Hypersensitivity, Delayed" by people in this website by year, and whether "Hypersensitivity, Delayed" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Hypersensitivity, Delayed" by people in Profiles.
Norris MR, Bielory L. Cosmetics and ocular allergy. Curr Opin Allergy Clin Immunol. 2018 10; 18(5):404-410.
Kocer N, Mondel PK, Yamac E, Kavak A, Kizilkilic O, Islak C. Is there an association between flow diverter fish mouthing and delayed-type hypersensitivity to metals?-a case-control study. Neuroradiology. 2017 Nov; 59(11):1171-1178.
Gómez D, Diehl MC, Crosby EJ, Weinkopff T, Debes GF. Effector T Cell Egress via Afferent Lymph Modulates Local Tissue Inflammation. J Immunol. 2015 Oct 15; 195(8):3531-6.
Phillips EA, Klein GR, Cates HE, Kurtz SM, Steinbeck M. Histological characterization of periprosthetic tissue responses for metal-on-metal hip replacement. J Long Term Eff Med Implants. 2014; 24(1):13-23.
Seidler DG, Mohamed NA, Bocian C, Stadtmann A, Hermann S, Schäfers K, Schäfers M, Iozzo RV, Zarbock A, Götte M. The role for decorin in delayed-type hypersensitivity. J Immunol. 2011 Dec 1; 187(11):6108-19.
Mahipal A, Terai M, Berd D, Chervoneva I, Patel K, Mastrangelo MJ, Sato T. Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine. Cancer Immunol Immunother. 2011 Jul; 60(7):1039-45.
Lutz E, Yeo CJ, Lillemoe KD, Biedrzycki B, Kobrin B, Herman J, Sugar E, Piantadosi S, Cameron JL, Solt S, Onners B, Tartakovsky I, Choi M, Sharma R, Illei PB, Hruban RH, Abrams RA, Le D, Jaffee E, Laheru D. A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation. Ann Surg. 2011 Feb; 253(2):328-35.
Hong J, Bielory L. Allergy to ophthalmic preservatives. Curr Opin Allergy Clin Immunol. 2009 Oct; 9(5):447-53.
Dillman RO, Selvan SR, Schiltz PM, McClay EF, Barth NM, DePriest C, de Leon C, Mayorga C, Cornforth AN, Allen K. Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report. Cancer Biother Radiopharm. 2009 Jun; 24(3):311-9.
Dillman RO, Beutel L, Nayak S, Depriest C, Selvan S, Schiltz P. Cancer vaccine potency: is there a dose/response relationship for patient-specific vaccines and clinical outcomes? Cancer Biother Radiopharm. 2005 Aug; 20(4):373-8.